DOI: 10.1055/s-00000025

Hormone and Metabolic Research

Ausgabe 09 · Volume 41 · September 2009 DOI: 10.1055/s-002-20400

Editorial

655
Brown, M. J.; Grossman, A. B.; Bornstein, S. R.: Pheochromocytoma

Review

658
Manger, W. M.: The Protean Manifestations of Pheochromocytoma
664
Qin, Y.; Buddavarapu, K.; Dahia, P. L. M.: Pheochromocytomas: From Genetic Diversity to New Paradigms

Humans, Clinical

672
Cascón, A.; López-Jiménez, E.; Landa, I.; Leskelä, S.; Leandro-García, L. J.; Maliszewska, A.; Letón, R.; Vega, L. de la; García-Barcina, M. J.; Sanabria, C.; Álvarez-Escolá, C.; Rodríguez-Antona, C.; Robledo, M.: Rationalization of Genetic Testing in Patients with Apparently Sporadic Pheochromocytoma/Paraganglioma
676
Unger, N.; Deutschbein, T.; Walz, M. K.; Mann, K.; Petersenn, S.: The Value of Immunoassays for Metanephrines in the Biochemical Diagnosis of Pheochromocytomas

Review

680
Santarpia, L.; Habra, M. A.; Jiménez, C.: Malignant Pheochromocytomas and Paragangliomas: Molecular Signaling Pathways and Emerging Therapies
687
Adjallé, R.; Plouin, P. F.; Pacak, K.; Lehnert, H.: Treatment of Malignant Pheochromocytoma

Humans, Clinical

697
Druce, M. R.; Kaltsas, G. A.; Fraenkel, M.; Gross, D. J.; Grossman, A. B.: Novel and Evolving Therapies in the Treatment of Malignant Phaeochromocytoma: Experience with the mTOR Inhibitor Everolimus (RAD001)
703
Bravo, E. L.; Kalmadi, S. R.; Gill, I.: Clinical Utility of Temozolomide in the Treatment of Malignant Paraganglioma: A Preliminary Report

Review

707
Papewalis, C.; Kouatchoua, C.; Wuttke, M.; Jacobs, B.; Scherbaum, W. A.; Schott, M.: Chromogranin A as Potential Tumour Antigen in Pheochromocytoma

Original Basic

710
Powers, J. F.; Picard, K. L.; Tischler, A. S.: RET Expression and Neuron-like Differentiation of Pheochromocytoma and Normal Chromaffin Cells

Mini-Review

715
Carlsen, E.; Abdullah, Z.; Kazmi, S. M. B.; Kousparos, G.: Pheochromocytomas, PASS, and Immunohistochemistry